<?xml version="1.0" encoding="UTF-8"?>
<p>To gain more insight in replication of SHUV, virus titers were determined for virus-infected mosquito body and saliva samples. Titers of virus-infected 
 <italic>Cx</italic>. 
 <italic>p</italic>. 
 <italic>pipiens</italic> body samples were almost all below the detection limit of 10
 <sup>3</sup> TCID
 <sub>50</sub>/ml of the endpoint dilution assay (
 <xref ref-type="fig" rid="pntd.0006609.g003">Fig 3C</xref>). This indicates that even when SHUV is injected into the thorax, there is no productive virus replication. In contrast, we found mean titers of 1.1 x 10
 <sup>5</sup> TCID
 <sub>50</sub>/ml for virus-infected 
 <italic>Ae</italic>. 
 <italic>aegypti</italic> body samples. This shows that SHUV is able to successfully replicate in 
 <italic>Ae</italic>. 
 <italic>aegypti</italic> when the midgut barrier is bypassed. In the majority of mosquito saliva samples, SHUV titers were below the detection limit of 10
 <sup>3</sup> TCID
 <sub>50</sub>/ml of the endpoint dilution assay (
 <xref ref-type="fig" rid="pntd.0006609.g003">Fig 3D</xref>). Taken together, SHUV is able to disseminate in mosquitoes, but both the midgut and salivary glands form a barrier for SHUV.
</p>
